Efficacy and Safety of Ruxolitinib Cream in Patients With Lichen Sclerosus: Results From a Phase 2, Randomized, Double-Blind, Vehicle-Controlled Study
Published: 16 April 2026| Version 1 | DOI: 10.17632/v7w4p2x546.1
Contributor:
Description
Supplemental data for an article published in the Journal of the American Academy of Dermatology
Files
Categories
Ruxolitinib, Clinical Analysis, Janus Kinase